Nasus Pharma Ltd. (NSRX) IV/HV History

Comparing implied volatility to historical (realized) volatility reveals whether options are priced rich or cheap relative to actual price movement. Persistent gaps can signal trading opportunities.

Nasus Pharma Ltd. (NSRX) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $26.0M, listed on AMEX, employing roughly 2 people, carrying a beta of 3.89 to the broader market. Nasus Pharma is a clinical-stage specialty pharmaceutical company focused primarily on the development of intranasal drugs to treat emergency medical conditions such as severe allergies, anaphylaxis, and opioid overdose. Led by Dan Teleman, public since 2025-08-13.

IV/HV history compares implied volatility to realized volatility over time. No recent options activity for NSRX as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how implied vs realized volatility is reported and how to read the data →